161 related articles for article (PubMed ID: 9627295)
1. The addition of dexamethasone to antiandrogen therapy for hirsutism prolongs the duration of remission.
Carmina E; Lobo RA
Fertil Steril; 1998 Jun; 69(6):1075-9. PubMed ID: 9627295
[TBL] [Abstract][Full Text] [Related]
2. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
Carmina E; Lobo RA
Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone and spironolactone in the treatment of non-tumorous hyperandrogenism.
Prezelj J; Kocijancic A; Andolsek L
Gynecol Endocrinol; 1989 Dec; 3(4):281-8. PubMed ID: 2516705
[TBL] [Abstract][Full Text] [Related]
4. Recurrence rate of hirsutism after 3 different antiandrogen therapies.
Yücelten D; Erenus M; Gürbüz O; Durmuşoğlu F
J Am Acad Dermatol; 1999 Jul; 41(1):64-8. PubMed ID: 10411413
[TBL] [Abstract][Full Text] [Related]
5. Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism.
Lumachi F; Rondinone R
Fertil Steril; 2003 Apr; 79(4):942-6. PubMed ID: 12749435
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of hirsutism with spironolactone and with spironolactone plus dexamethasone].
Devoto E; Aravena L; Ríos R
Rev Med Chil; 2000 Aug; 128(8):868-75. PubMed ID: 11129548
[TBL] [Abstract][Full Text] [Related]
7. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Farquhar C; Lee O; Toomath R; Jepson R
Cochrane Database Syst Rev; 2003; (4):CD000194. PubMed ID: 14583916
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
[TBL] [Abstract][Full Text] [Related]
9. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Farquhar C; Lee O; Toomath R; Jepson R
Cochrane Database Syst Rev; 2001; (4):CD000194. PubMed ID: 11687072
[TBL] [Abstract][Full Text] [Related]
10. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Lee O; Farquhar C; Toomath R; Jepson R
Cochrane Database Syst Rev; 2000; (2):CD000194. PubMed ID: 10796700
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the clinical efficacy of flutamide and spironolactone plus Diane 35 in the treatment of idiopathic hirsutism: a randomized controlled study.
Inal MM; Yildirim Y; Taner CE
Fertil Steril; 2005 Dec; 84(6):1693-7. PubMed ID: 16359967
[TBL] [Abstract][Full Text] [Related]
12. Prospective randomized study comparing the long-acting gonadotropin-releasing hormone agonist triptorelin, flutamide, and cyproterone acetate, used in combination with an oral contraceptive, in the treatment of hirsutism.
Pazos F; Escobar-Morreale HF; Balsa J; Sancho JM; Varela C
Fertil Steril; 1999 Jan; 71(1):122-8. PubMed ID: 9935128
[TBL] [Abstract][Full Text] [Related]
13. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Brown J; Farquhar C; Lee O; Toomath R; Jepson RG
Cochrane Database Syst Rev; 2009 Apr; (2):CD000194. PubMed ID: 19370553
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects.
Fruzzetti F; Bersi C; Parrini D; Ricci C; Genazzani AR
Fertil Steril; 1999 Mar; 71(3):445-51. PubMed ID: 10065780
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism.
Erenus M; Gürbüz O; Durmuşoğlu F; Demirçay Z; Pekin S
Fertil Steril; 1994 Apr; 61(4):613-6. PubMed ID: 8150100
[TBL] [Abstract][Full Text] [Related]
16. A comparison between spironolactone and spironolactone plus finasteride in the treatment of hirsutism.
Keleştimur F; Everest H; Unlühizarci K; Bayram F; Sahin Y
Eur J Endocrinol; 2004 Mar; 150(3):351-4. PubMed ID: 15012621
[TBL] [Abstract][Full Text] [Related]
17. Hirsutism in Women.
Matheson E; Bain J
Am Fam Physician; 2019 Aug; 100(3):168-175. PubMed ID: 31361105
[TBL] [Abstract][Full Text] [Related]
18. Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
Erenus M; Yücelten D; Gürbüz O; Durmuşoğlu F; Pekin S
Fertil Steril; 1996 Aug; 66(2):216-9. PubMed ID: 8690104
[TBL] [Abstract][Full Text] [Related]
19. Antiandrogenic properties of spironolactone. Clinical trial in the management of female hirsutism.
Messina M; Manieri C; Biffignandi P; Massucchetti C; Novi RF; Molinatti GM
J Endocrinol Invest; 1983 Feb; 6(1):23-7. PubMed ID: 6404979
[TBL] [Abstract][Full Text] [Related]
20. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial.
Moghetti P; Tosi F; Tosti A; Negri C; Misciali C; Perrone F; Caputo M; Muggeo M; Castello R
J Clin Endocrinol Metab; 2000 Jan; 85(1):89-94. PubMed ID: 10634370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]